Iris Mora Tejeda
Nurse Practitioner · Pembroke Pines, FLNPI 1194446385
Payments from drug & device makers
Across 86 payments — averaging $22.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$212
- Otsuka America Pharmaceutical, Inc.$176
- Mallinckrodt Hospital Products Inc.$158
- GSK$151
- Bayer$145
- Lundbeck LLC$124
- plus $965 from 24 others
What the payments were for
- Food & beverage$1,930100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 10 | $212 |
| Otsuka America Pharmaceutical, Inc. | 7 | $176 |
| Mallinckrodt Hospital Products Inc. | 5 | $158 |
| GSK | 8 | $151 |
| Bayer | 7 | $145 |
| Lundbeck LLC | 4 | $124 |
| Abbott | 4 | $120 |
| Exact Sciences | 5 | $118 |
| AstraZeneca | 5 | $107 |
| Lilly USA, LLC | 5 | $96 |
| Boehringer Ingelheim | 3 | $70 |
| Corcept Therapeutics | 2 | $43 |
| Calliditas Therapeutics US Inc. | 2 | $40 |
| AbbVie | 2 | $37 |
| Dexcom, Inc. | 2 | $35 |
| Kyowa Kirin, Inc. | 1 | $28 |
| Amgen | 1 | $28 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Idorsia Pharmaceuticals US Inc | 1 | $22 |
| Novartis | 1 | $22 |
| Cvrx, Inc. | 1 | $21 |
| Pfizer | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $19 |
| Almatica Pharma LLC | 1 | $17 |
| Inspire Medical Systems, Inc. | 1 | $17 |
| Johnson & Johnson | 1 | $17 |
| IBSA Pharma Inc. | 1 | $17 |
| Akebia Therapeutics Inc | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Evoke Pharma, Inc. | 1 | $14 |
How this compares
$1,930 in reported general payments places this provider in the 80th percentile of 8,290 nurse practitioner providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 34 | $33,828 |
| LinzessLinaclotide | 16 | $16,197 |
| FarxigaDapagliflozin Propanediol | 12 | $13,085 |
| RybelsusSemaglutide | 12 | $10,985 |
| SynthroidLevothyroxine Sodium | 15 | $1,904 |
| Levothyroxine Sodium | 100 | $1,246 |
| Nifedipine ErNifedipine | 43 | $1,159 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 32 | $1,119 |
| Losartan Potassium | 83 | $1,108 |
| Olmesartan-HydrochlorothiazideOlmesartan/Hydrochlorothiazide | 12 | $895 |
| Atorvastatin Calcium | 90 | $739 |
| Gabapentin | 62 | $645 |
| Alprazolam | 145 | $625 |
| Rosuvastatin Calcium | 56 | $621 |
| Metoprolol Succinate | 29 | $569 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $20 | $33,82834 claims |
| AbbVieLinzess, Synthroid | $37 | $18,10131 claims |
| AstraZenecaFarxiga | $107 | $13,08512 claims |
| Novo NordiskRybelsus | $212 | $10,98512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 8,290 nurse practitioner providers in Florida.
Other nurse practitioner in Pembroke Pines
- Stephanie PhillipsPembroke Pines$86K
- Leticia AnonPembroke Pines$24K
- Jolanta BaginskiClearwater$494K
- Adissa PerezWinter Park$370K
- April WessonTampa$342K
- Margarita FernandezMiami$311K
- Stephanie SimmermanNaples$283K
- Claudette WalkerPonte Vedra Beach$271K
- Lisa NodzonTampa$246K
- Ashima BahlTampa$226K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.